StemCells Therapy |

Mar/10

10

Life Tech CEO’s 2009 compensation falls 60 percent with no stock options, restricted stock

Life Technologies CEO’s 2009 compensation falls

NEW YORK — Life Technologies Corp. Chairman and CEO Gregory Lucier’s compensation fell 60 percent to just over $4.5 million in 2009 on a lack of stock awards, according to an Associated Press calculation of figures disclosed in a regulatory filing.
In 2009, Lucier received a 14 percent boost in salary … Original source on Gaea Times at : Life Tech CEO’s 2009 compensation falls 60 percent with no stock options, restricted stock.

RSS Feed

No comments yet.

Leave a comment!

You must be logged in to post a comment.

«

»

Find it!

Theme Design by devolux.org

Tag Cloud







Personalized Gene Medicine | Mesenchymal Stem Cells | Stem Cell Treatment for Multiple Sclerosis | Stem Cell Treatments | Board Certified Stem Cell Doctors | Stem Cell Medicine | Personalized Stem Cells Therapy | Stem Cell Therapy TV | Individual Stem Cell Therapy | Stem Cell Therapy Updates | MD Supervised Stem Cell Therapy | IPS Stem Cell Org | IPS Stem Cell Net | Genetic Medicine | Gene Medicine | Longevity Medicine | Immortality Medicine | Nano Medicine | Gene Therapy MD | Individual Gene Therapy | Affordable Stem Cell Therapy | Affordable Stem Cells | Stem Cells Research | Stem Cell Breaking Research

Web Design by PlatinumShore.com & Web Hosting by TradeWebHosting.com